Analysts at Zacks Investment Research upgraded shares of Ritter Pharmaceuticals Inc (NASDAQ: RTTR) from Sell to Hold today. With a rating of Hold on the stock, Ritter Pharmaceuticals Inc has a 52-week high of $3.13. The one-year price target of …

Ritter Pharmaceuticals Inc (NASDAQ: RTTR) Stock Upgraded at Zacks Investment Research
Leave a reply